Location: Home >> Special Issue
Special Issue
Dear colleagues,
The special issue titled "Precision Medicine: Personalized Treatment and Genomic Medicine" focuses on the transformative approach of precision medicine, which tailors healthcare strategies to the individual characteristics of patients. It highlights the integration of genomic information into clinical practice, leading to more targeted therapies, improved drug efficacy, and better patient outcomes.Key topics in this special issue include advancements in genomic sequencing technologies, the role of biomarkers in diagnosing and monitoring diseases, and the significance of pharmacogenomics in personalizing medication. Overall, this issue emphasizes the potential of personalized approaches to revolutionize treatment methodologies and enhance healthcare delivery. This special issue of International Journal of Clinical and Experimental Medicine Research including but not limited to the following topics:
Genomic Sequencing Technologies
Targeted Cancer Therapies:
Pharmacogenomics
Biomarkers in Disease
Clinical Applications of Genomics
Genetic Risk Assessment
Rare Genetic Disorders
Integrating Big Data in Healthcare
Patient-Centered Care Models
Artificial Intelligence in Genomics
Microbiome and Health
Gene Editing Technologies
Longitudinal Studies in Precision Medicine
Health Disparities in Genomic Medicine
Authors should submit their manuscripts for the special issue by emailing them as an attachment to specialissue@hillpublish.com or by using the online submission system. The manuscript should be submitted by one of the authors, and submissions by anyone other than the authors will not be accepted. Additionally, the submitted manuscript should include a cover letter that specifies the special issue to which the manuscript is being submitted.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). The submitted papers should be properly formatted and written in fluent English. All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Guidelines page.
December 31, 2024